T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.97% |
| 2 | Financials | 16.84% |
| 3 | Technology | 15.92% |
| 4 | Consumer Discretionary | 13.45% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
1551
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.17M | ﹤0.01% |
134,361
| – | – |
|
1552
Avista
AVA
$3.25B
| $2.17M | ﹤0.01% |
41,871
-2,357
| -5% | -$118K |
|
1553
New Jersey Resources
NJR
$5.64B
| $2.16M | ﹤0.01% |
51,291
-6
| -0% | -$254 |
|
|
LPT
1554
DELISTED
Liberty Property Trust
LPT
| $2.16M | ﹤0.01% |
52,586
+10
| +0% | +$418 |
|
|
DHC
1555
Diversified Healthcare Trust
DHC
$2.04B
| $2.15M | ﹤0.01% |
109,905
-8,823
| -7% | -$172K |
|
1556
Omega Healthcare
OHI
$13.9B
| $2.15M | ﹤0.01% |
67,306
| – | – |
|
1557
JetBlue
JBLU
$2.17B
| $2.15M | ﹤0.01% |
115,872
-3,380
| -3% | -$70.9K |
|
|
TECD
1558
DELISTED
Tech Data Corp
TECD
| $2.14M | ﹤0.01% |
24,072
+2,633
| +12% | +$260K |
|
1559
Huntsman Corp
HUN
$1.82B
| $2.12M | ﹤0.01% |
77,422
+9,961
| +15% | +$265K |
|
1560
Axalta
AXTA
$7.97B
| $2.09M | ﹤0.01% |
72,317
-491,909
| -87% | -$14.9M |
|
1561
EPR Properties
EPR
$4.74B
| $2.08M | ﹤0.01% |
29,827
+33
| +0.1% | +$2.32K |
|
|
SKX
1562
DELISTED
Skechers
SKX
| $2.06M | ﹤0.01% |
82,260
-3,716,970
| -98% | -$102M |
|
1563
ITT
ITT
$19.5B
| $2.06M | ﹤0.01% |
46,509
+7
| +0% | +$288 |
|
1564
Ryman Hospitality Properties
RHP
$7.98B
| $2.06M | ﹤0.01% |
32,919
-1,732
| -5% | -$106K |
|
1565
Core Laboratories
CLB
$576M
| $2.04M | ﹤0.01% |
20,720
-30,882
| -60% | -$2.99M |
|
1566
AMC Global Media
AMCX
$500M
| $2.04M | ﹤0.01% |
34,818
-4,867
| -12% | -$290K |
|
|
VR
1567
DELISTED
Validus Hold Ltd
VR
| $2.03M | ﹤0.01% |
41,164
-30
| -0.1% | -$1.52K |
|
|
NUAN
1568
DELISTED
Nuance Communications, Inc.
NUAN
| $2.01M | ﹤0.01% |
147,521
+17,671
| +14% | +$252K |
|
1569
Brown-Forman Class A
BF.A
$13.1B
| $2M | ﹤0.01% |
45,000
| – | – |
|
|
TCF
1570
DELISTED
TCF Financial Corporation
TCF
| $2M | ﹤0.01% |
117,357
+12,993
| +12% | +$205K |
|
1571
Lamb Weston
LW
$7.32B
| $2M | ﹤0.01% |
42,559
+15
| +0% | +$673 |
|
1572
Bio-Techne
TECH
$11.2B
| $1.99M | ﹤0.01% |
65,784
+80
| +0.1% | +$2.37K |
|
1573
AptarGroup
ATR
$8.29B
| $1.99M | ﹤0.01% |
23,004
-7,299
| -24% | -$621K |
|
|
GPOR
1574
DELISTED
Gulfport Energy Corp.
GPOR
| $1.98M | ﹤0.01% |
137,975
+11,000
| +9% | +$143K |
|
1575
Rithm Capital
RITM
$5.79B
| $1.98M | ﹤0.01% |
118,075
+12,610
| +12% | +$207K |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.